Reaction

Thyroid Function Test Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,122 reports · 59 co-occurring drugs

As of the last recalculation, Thyroid Function Test Abnormal appears in 4,122 FAERS reports alongside 59 co-occurring drug terms. The strongest observed disproportionality signal is LIOTHYRONINE SODIUM (PRR 35.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Liothyronine Sodium	60	35.3	35.5
Levothyroxine Sodium	1,168	25.8	25.9
Alemtuzumab	94	25.1	25.2
Thyroid, Porcine	41	19.6	19.7
Sunitinib Malate	108	14.2	14.3
Amiodarone Hydrochloride	31	14.1	14.1
Methimazole	20	12.9	13.0
Lenvatinib	67	10.5	10.5
Levothyroxine Sodium Anhydrous	186	9.8	9.8
Cabozantinib	89	9.5	9.6
Dimenhydrinate	18	8.6	8.6
Pazopanib Hydrochloride	38	7.1	7.2
Cimetidine	13	6.8	6.8
Rucaparib	11	6.3	6.3
Nivolumab	117	6.3	6.3
Peginterferon Alfa-2A	64	6.1	6.1
Axitinib	23	6.0	6.0
Ipilimumab	50	5.9	5.9
Interferon Beta-1B	22	5.8	5.8
Lithium Carbonate	19	5.7	5.7
Avapritinib	13	5.4	5.4
Lanreotide Acetate	8	5.2	5.2
Pembrolizumab	101	4.9	4.9
Dofetilide	10	4.8	4.8
Octreotide Acetate	29	4.8	4.8
Dronedarone	9	4.5	4.5
Diphenoxylate Hydrochloride And Atropine Sulfate	12	4.4	4.4
Butalbital, Acetaminophen, And Caffeine	9	4.3	4.3
Biotin	26	4.2	4.2
Lithium	20	4.0	4.0
Lithium Bromatum	20	4.0	4.0
Loperamide Hydrochloride Oral	8	4.0	4.0
Ziprasidone Mesylate	11	3.9	3.9
Fish Oil	66	3.7	3.7
Ribavirin	42	3.3	3.3
Nebivolol Hydrochloride	22	3.3	3.3
Ziprasidone	11	3.2	3.2
Interferon Beta-1A	118	3.1	3.1
Loperamide Hcl	8	3.1	3.1
Modafinil	20	3.1	3.1
Niraparib	13	3.0	3.0
Durvalumab	11	2.7	2.7
Armodafinil	11	2.6	2.6
Regorafenib	6	2.6	2.6
Apalutamide	6	2.6	2.6
Teriflunomide	23	2.6	2.6
Encorafenib	5	2.6	2.6
Icosapent Ethyl	4	2.4	2.4
Exenatide	22	2.1	2.1
Desvenlafaxine Succinate	11	2.1	2.1
Teriparatide	41	1.8	1.8
Drospirenone And Ethinyl Estradiol	16	1.8	1.8
Varenicline Tartrate	28	1.8	1.8
Fremanezumab-Vfrm	4	1.8	1.8
Abaloparatide	10	1.7	1.7
Peginterferon Beta-1A	4	1.5	1.5
Natalizumab	52	1.5	1.5
Somatropin	15	1.0	1.0
Voxelotor	3	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.